Chive-derived nanoparticles may help reduce inflammation in obesity
Role of chive-derived exosome-like nanoparticles in suppressing inflammation in obesity
This study is looking at how tiny particles made from chives might help reduce inflammation caused by obesity, which can lead to health issues like heart disease and diabetes, and it aims to find new ways to improve health for people dealing with obesity.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11017792 on NIH RePORTER |
What this research studies
This research investigates how nanoparticles derived from chives can suppress inflammation associated with obesity. The study focuses on the NLRP3 inflammasome, a key player in the inflammatory response linked to obesity-related diseases like heart disease and type 2 diabetes. By exploring the effects of chive-derived exosome-like nanoparticles (C-ELNs), the researchers aim to develop a new dietary strategy or therapeutic approach to mitigate inflammation and improve metabolic health. Initial findings suggest that these nanoparticles can inhibit inflammation in laboratory settings, which could lead to innovative treatments for patients suffering from obesity and its complications.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults struggling with obesity or related metabolic disorders, such as type 2 diabetes.
Not a fit: Patients who are not affected by obesity or do not have related metabolic conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a novel dietary intervention to reduce inflammation and improve health outcomes for individuals with obesity.
How similar studies have performed: While the specific approach using chive-derived nanoparticles is novel, similar strategies targeting inflammation in obesity have shown promise in other studies.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Yu, Jiujiu — Case Western Reserve University
- Study coordinator: Yu, Jiujiu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.